SCHEMBL7438527

SCHEMBL7438527

CC(=O)c1ccc2c(c1)C(C)(C=S)C(=O)N2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 4/20 0.52
PDE3B Q13370 1/20 0.41
PDE3A Q14432 1/20 0.41
IP6K1 Q92551 1/20 0.39
TLK2 Q86UE8 5/20 0.38
GAA P10253 2/20 0.37
IDO1 P14902 1/20 0.37
PDK2 Q15119 1/20 0.37
PDK4 Q16654 1/20 0.37
MAPT P10636 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SLC2A1 P11166 1/20 0.35
MEN1 O00255 1/20 0.35
CYBB P04839 1/20 0.35
APP P05067 1/20 0.35
ALOX15 P16050 1/20 0.35
SNCA P37840 1/20 0.35
KMT2A Q03164 1/20 0.35
NOX3 Q9HBY0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7427902 0.75 PGR (0.50) PGRPDE3BPDE3AIP6K1TLK2
SCHEMBL7438531 0.75 PGR (0.50) PGRPDE3BPDE3AIP6K1TLK2
SCHEMBL1764545 0.73 HDAC3 (0.54) PGRIP6K1GAAMAPTNPC1
SCHEMBL20268826 0.72 IP6K1 (0.55) PGRPDE3BPDE3AIP6K1MAPK14
SCHEMBL20268320 0.72 IP6K1 (0.55) PGRPDE3BPDE3AIP6K1MAPK14
SCHEMBL1874397 0.70 PGR (0.55) PGRPDE3BPDE3AIP6K1PDK2
SCHEMBL27076405 0.70 MAPT (0.45) PGRTLK2GAAMAPTNPC1
SCHEMBL15040978 0.67 MAPT (0.53) PGRPDK2MAPTNPC1RAB9A
SCHEMBL7379550 0.67 PGR (0.51) PGRPDE3BPDE3APDK2PDK4
SCHEMBL31117105 0.67 PGR (0.51) PGRPDE3BPDE3APDK2PDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4933336-A Thiadiazinone, oxadiazinone and triazinone derivatives, and their use for treating acute or chronic heart disease LABORATOIRES SOBIO S.A. (FR) 1990-06-12 US disclosed
EP-0303418-A2 Substituted indolones, useful in the treatment of heart or asthmatic diseases SMITHKLINE BEECHAM LABORATOIRES PHARMACEUTIQUES (FR) 1989-02-15 EP disclosed